Enhao Gong, PhD
Enhao Gong, the founder and CEO of Subtle Medical, is a visionary and pioneering researcher in AI-driven medical imaging, revolutionizing healthcare by enhancing diagnostic accuracy and patient outcomes through AI and generative models. From his early PhD work in GANs (generative adversarial network deep learning architecture), he pushed innovations in faster and after imaging with better efficiency, better quality and lower radiation dose. Enhao has demonstrated exceptional leadership and technological expertise, pushing boundaries to make advanced imaging faster, safer, and more accessible. His focus on applying AI and generative AI to imaging acquisition, reconstruction and enhancement is reshaping how medical data is processed, visualized and interpreted.
Enhao’s approach is deeply rooted in his dedication to advancing patient care and safety. His innovations have optimized time, resource, and dosage requirements for high-quality imaging, providing clinicians and patients with enhanced workflow efficiency and reducing risks associated with traditional imaging protocols.
What distinguishes Enhao is his steadfast commitment to leveraging AI to address tangible healthcare challenges on the workflow instead of replacing radiologists. He has not only developed cutting-edge AI technologies but also has ensured their impactful adoption across diverse medical environments, pushing 600+ sites globally from local clinics, large radiology practices to global healthcare systems that touch 2.5 million patients annually. Under his leadership, these technologies have been translated into eight FDA-cleared AI products, a testament to his ability to bridge the gap between innovation and practical implementation.
Beyond his technical achievements, Enhao is a respected leader and mentor in the AI and healthcare communities. He founded the startup commercializing the very AI/GenAI technologies which secured $50M funding from top investors and 8 FDA clearances so far. Recognized with awards such as Forbes 30 Under 30, Fortune 40 Under 40, CB Insight top GenAI companies, Stanford GenAI Healthcare award, and the NVIDIA AI Award, he actively contributes by speaking at industry conferences, where he shares insights on the ethical deployment of AI in medicine, inspiring the next wave of innovators. In a field where breakthroughs are challenging, Enhao’s accomplishments are both pioneering and impactful, embodying excellence in AI and healthcare.